Intrasplenic Transplantation of Islets With a Platelet Shielding System Restores Glycemic Control
Diabetes · 01.08.2025 · 74 (8) · 1385-1398
DOI: 10.2337/db24-0856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 30.05.2025. Verfasst von Lin Song und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Spleen, Islets of Langerhans, Blood Glucose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Intraportal islet transplantation to treat insulin-dependent diabetes has been clinically validated. However, the hypoxic environment and sinusoidal architecture of the liver are unsuitable for the long-term survival of transplanted islets, leading to the loss of therapeutic effects within 1 year. The spleen has oxygen levels that meet islet needs, but intense instant blood-mediated inflammatory reactions (IBMIRs) and low extracellular matrix (ECM) concentrations hinder islet engraftment and survival. In this study, we developed constructs of islets encapsulated by hepatocytes and fibroblasts. The hepatocytes and fibroblasts create a protective coating that reduces IBMIRs because of the low expression of von Willebrand factor in hepatocytes and supports normal islet survival through ECM production by fibroblasts. These constructs can be easily injected into the mouse spleen. The hepatocyte–fibroblast encapsulation significantly reduces islet mortality during the posttransplantation stress period, enabling rapid engraftment and vascularization in the spleen. The high-oxygen environment of the spleen then supports long-term (>1 year) islet survival and sustained glycemic regulation. Additionally, this method significantly lowers the critical islet dose required for transplantation. The live cell–shielding strategy developed in this study represents a novel approach in islet transplantation and functional regeneration, demonstrating promising clinical potential. Article Highlights Instant blood-mediated inflammatory reactions (IBMIRs) and low extracellular matrix (ECM) concentrations hinder islet implantation and survival in the spleen. Islets were encapsulated in hepatocytes and fibroblasts. The low expression of von Willebrand factor in hepatocytes enables them to form a protective coating with fibroblasts. This coating reduces IBMIRs and supports islet survival through ECM production by fibroblasts. The hepatocyte–fibroblast encapsulation significantly reduces islet mortality during the posttransplantation stress period, enabling rapid engraftment and vascularization in the spleen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
- Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
- Guangxi Medical University, Nanning, Guangxi, China.
- Department of Physiology and Pathophysiology, Yulin Campus of Guangxi Medical University, Yulin, Guangxi, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau SAR.
- Institute of Transplantation Medicine, Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
ORCID-Profile: Junfeng Zhang, Xuyong Sun, Lei Dong
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, L., Liu, C., Yang, A., Zhang, X., Wang, X., Teng, Y., Lu, D., Kuang, X., Wang, C., Zhang, J., Sun, X., & Dong, L. (2025). Intrasplenic Transplantation of Islets With a Platelet Shielding System Restores Glycemic Control. Diabetes, 74(8), 1385-1398. https://doi.org/10.2337/db24-0856
Vancouver
Song L, Liu C, Yang A, Zhang X, Wang X, Teng Y, et al. Intrasplenic Transplantation of Islets With a Platelet Shielding System Restores Glycemic Control. Diabetes. 2025;74(8):1385-1398. doi:10.2337/db24-0856
BibTeX
@article{Song2025,
author = {Song, Lin and Liu, Chunyan and Yang, Anqi and Zhang, Xiaohai and Wang, Xintong and Teng, Yanjiao and Lu, Decheng and Kuang, Xiaocong and Wang, Chunming and Zhang, Junfeng and Sun, Xuyong and Dong, Lei},
title = {Intrasplenic Transplantation of Islets With a Platelet Shielding System Restores Glycemic Control},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {8},
pages = {1385--1398},
doi = {10.2337/db24-0856}
}
EUVIMED